<?xml version="1.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="https://dirros.openscience.si/IzpisGradiva.php?id=28732"><dc:title>Age-related effects of COVID-19 pandemic on mechanical reperfusion and 30-day mortality for STEMI</dc:title><dc:creator>De Luca,	Giuseppe	(Avtor)
	</dc:creator><dc:creator>Algowhary,	Magdy	(Avtor)
	</dc:creator><dc:creator>Uguz,	Berat	(Avtor)
	</dc:creator><dc:creator>Oliveira,	Dinaldo C.	(Avtor)
	</dc:creator><dc:creator>Ganyukov,	Vladimir	(Avtor)
	</dc:creator><dc:creator>Busljetik,	Oliver	(Avtor)
	</dc:creator><dc:creator>Čerček,	Miha	(Avtor)
	</dc:creator><dc:subject>ageing</dc:subject><dc:subject>ST-segment elevation myocardial infarction</dc:subject><dc:subject>COVID-19</dc:subject><dc:description>Background: The constraints in the management of patients with ST-segment elevation myocardial infarction (STEMI) during the COVID-19 pandemic have been suggested to have severely impacted mortality levels. The aim of the current analysis is to evaluate the age-related effects of the COVID-19 pandemic on mechanical reperfusion and 30-day mortality for STEMI within the registry ISACS-STEMI COVID-19. Methods: This retrospective multicenter registry was performed in high-volume PPCI centers on four continents and included STEMI patients undergoing PPCI in March–June 2019 and 2020. Patients were divided according to age (&lt; or ≥75 years). The main outcomes were the incidence and timing of PPCI, (ischemia time longer than 12 h and door-to-balloon longer than 30 min), and in-hospital or 30-day mortality. Results: We included 16,683 patients undergoing PPCI in 109 centers. In 2020, during the pandemic, there was a significant reduction in PPCI as compared to 2019 (IRR 0.843 (95%-CI: 0.825–0.861, p &lt; 0.0001). We found a significant age-related reduction (7%, p = 0.015), with a larger effect on elderly than on younger patients. Furthermore, we observed significantly higher 30-day mortality during the pandemic period, especially among the elderly (13.6% vs. 17.9%, adjusted HR (95% CI) = 1.55 [1.24–1.93], p &lt; 0.001) as compared to younger patients (4.8% vs. 5.7%; adjusted HR (95% CI) = 1.25 [1.05–1.49], p = 0.013), as a potential consequence of the significantly longer ischemia time observed during the pandemic. Conclusions: The COVID-19 pandemic had a significant impact on the treatment of patients with STEMI, with a 16% reduction in PPCI procedures, with a larger reduction and a longer delay to treatment among elderly patients, which may have contributed to increase in-hospital and 30-day mortality during the pandemic.</dc:description><dc:date>2023</dc:date><dc:date>2026-03-31 12:24:49</dc:date><dc:type>Neznano</dc:type><dc:identifier>28732</dc:identifier><dc:language>sl</dc:language></rdf:Description></rdf:RDF>
